Euin Cheong, OD

Dual-purpose therapeutics help patients with both conditions.

Clinicians may have difficulty in making a diagnosis.

Unpacking the connection between type 2 diabetes and Alzheimer disease.

Pegcetacoplan’s recent FDA approval creates an option for patients with dry AMD.

Advances in drug creation would reduce cost burden of treatment for patients.

Benefits include eliminating eyeglass problems and boosting patient confidence.

DigitalOptometrics President discusses the pioneering abilities of telemedicine and how the company is paving a new way for doctors to see patients of varying needs.

Check out expert insight on the most recent lens launches to expand the options accessible to our patients based on their specific needs.

Consider topical therapies as second-line treatments for this patient base.

Follow this expert advice for an easy navigation process.